These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 16959385

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Immunisation against plague by transcutaneous and intradermal application of subunit antigens.
    Eyles JE, Elvin SJ, Westwood A, Lebutt CS, Alpar HO, Somavarapu S, Williamson ED.
    Vaccine; 2004 Oct 22; 22(31-32):4365-73. PubMed ID: 15474730
    [Abstract] [Full Text] [Related]

  • 26. Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine.
    Elvin SJ, Eyles JE, Howard KA, Ravichandran E, Somavarappu S, Alpar HO, Williamson ED.
    Vaccine; 2006 May 15; 24(20):4433-9. PubMed ID: 16546306
    [Abstract] [Full Text] [Related]

  • 27. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
    Amemiya K, Meyers JL, Rogers TE, Fast RL, Bassett AD, Worsham PL, Powell BS, Norris SL, Krieg AM, Adamovicz JJ.
    Vaccine; 2009 Apr 06; 27(16):2220-9. PubMed ID: 19428836
    [Abstract] [Full Text] [Related]

  • 28. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.
    Honko AN, Sriranganathan N, Lees CJ, Mizel SB.
    Infect Immun; 2006 Feb 06; 74(2):1113-20. PubMed ID: 16428759
    [Abstract] [Full Text] [Related]

  • 29. Prospects for new plague vaccines.
    Feodorova VA, Corbel MJ.
    Expert Rev Vaccines; 2009 Dec 06; 8(12):1721-38. PubMed ID: 19943765
    [Abstract] [Full Text] [Related]

  • 30. Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague.
    Reed DS, Martinez MJ.
    Vaccine; 2006 Mar 20; 24(13):2283-9. PubMed ID: 16377037
    [Abstract] [Full Text] [Related]

  • 31. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice.
    Bozue J, Cote CK, Webster W, Bassett A, Tobery S, Little S, Swietnicki W.
    FEMS Microbiol Lett; 2012 Jul 20; 332(2):113-21. PubMed ID: 22537022
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Evaluation of immunization protection efficacy of plague subunit vaccine].
    Zhang QW, Qi ZZ, Xin YQ, Yang YH, Wu HL, Yang HQ, Feng JP, Jin X, Cui BZ, Wang T, Wu BC, Qiu YF, Wang W, Guo ZB, Wang ZY, Yang RF, Wang H, Wang XY.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Sep 20; 43(9):785-8. PubMed ID: 20137561
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis.
    Bhattacharya D, Mecsas J, Hu LT.
    Vaccine; 2010 Nov 10; 28(48):7683-9. PubMed ID: 20875494
    [Abstract] [Full Text] [Related]

  • 37. Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague.
    Davies ML, Biryukov SS, Rill NO, Klimko CP, Hunter M, Dankmeyer JL, Miller JA, Shoe JL, Mlynek KD, Talyansky Y, Toothman RG, Qiu J, Bozue JA, Cote CK.
    Front Immunol; 2024 Nov 10; 15():1397579. PubMed ID: 38835755
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Different strategies for preparation of non-tagged rV270 protein and its efficacy against Yersinia pestis challenge.
    Wang W, Qi ZZ, Zhang QW, Wu BC, Zhu ZW, Yang YH, Cui BZ, Dai RX, Qiu YF, Wang ZY, Guo ZB, Shi TX, Wang H, Yang RF, Wang XY.
    Biomed Environ Sci; 2010 Oct 10; 23(5):333-40. PubMed ID: 21112480
    [Abstract] [Full Text] [Related]

  • 40. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.
    Montminy SW, Khan N, McGrath S, Walkowicz MJ, Sharp F, Conlon JE, Fukase K, Kusumoto S, Sweet C, Miyake K, Akira S, Cotter RJ, Goguen JD, Lien E.
    Nat Immunol; 2006 Oct 10; 7(10):1066-73. PubMed ID: 16980981
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.